Eszopiclone Online



How and where to order Eszopiclone (Lunesta) 2 mg, 3 mg tablets online on the Foundation for Life Care Planning Research website:

Shop 1:MEDS DIRECT SHOP
Shop 2:MEDSTORE ONLINE
Prices:from $1.13 per pill
Forms:Eszopiclone (Lunesta, Zunestar) 2 mg, 3 mg tablets
Quantity:30, 60, 90, 120, 200, 300 pills
Type:Eszopiclone brand, Zunestar brand, Lunesta generic
Payment:Visa, Mastercard, Bitcoin
Delivery:Registered airmail, international delivery service
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia


Eszopiclone (trade names include Lunesta, Eszop, Fulnite, Night Calm, Novo Insomnium, Valnoc, Zunestar) is a hypnotic and sedative medication from benzodiazepine related drugs pharmacological group. This medicine is used for the therapy of insomnia, especially where difficulty in falling asleep is the primary complaint. It causes relaxation to help you fall asleep and stay asleep. Eszopiclone works by affecting some chemicals in human brain that may become unbalanced and cause sleep problems (insomnia).


Lunesta (Eszopiclone) 1 mg, 2 mg, 3 mg tablets


Related medications:

  • Alprazolam (Xanax)
  • Apronal (Sedormid)
  • Butobarbital (Soneryl)
  • Chloralodol (Mechloral)
  • Chlormethiazole (Clomethiazole)
  • Dexmedetomidine (Precedex)
  • Diazepam (Valium)
  • Flunitrazepam (Rohypnol)
  • Lorazepam (Ativan)
  • Melatonin (Circadin)
  • Methaqualone (Quaalude)
  • Methylpentynol (Dormison)
  • Midazolam (Versed)
  • Modafinil (Provigil)
  • Niaprazine (Nopron)
  • Nitrazepam (Mogadon)
  • Pentobarbital (Nembutal)
  • Pyrithyldione (Presidon)
  • Ramelteon (Rozerem)
  • Temazepam (Restoril)
  • Zaleplon (Sonata)
  • Zolpidem (Ambien)
  • Zopiclone (Imovane)


    Pharmacological and medical categories:

  • Anti-insomnia medications
  • Anticonvulsants
  • Anxiolytics
  • Central muscle relaxants
  • Cyclopyrrolones
  • Drugs for the treatment of sleep disorders
  • Hypnotic and sedative medicines
  • Nonbenzodiazepines
  • Sleep aid medications
  • Sleeping pills
  • Z-drugs


    ATC codes:

  • N - Nervous system
  • N05 - Psycholeptics
  • N05C - Hypnotics and sedatives
  • N05CF - Benzodiazepine related drugs
  • N05CF04 - Eszopiclone


    ICD-10 codes:

  • Nonorganic sleep disorders - F51
  • Sleep disorders - G47


    Indications and usage:

    Lunesta is indicated for the treatment of insomnia. Eszopiclone has been shown to decrease sleep latency and improve sleep maintenance.


    Dosage and administration:

  • Use the lowest dose effective for the patient.
  • Recommended initial dose is 1 mg, immediately before bedtime, withat least 7-8 hours remaining before the planned time of awakening. May increase dose if clinically indicated, to a maximum of 3 mg.
  • Geriatric or debilitated patients: dose should not exceed 2 mg.
  • Patients with severe hepatic impairment, or taking potent CYP3A4 inhibitors: dose should not exceed 2 mg.
  • Do not take with or immediately after a meal.


    Dosage forms and strengths:

    Lunesta (Eszopiclone) tablets: 1 mg, 2 mg, and 3 mg.


    Overdosage:

    In clinical trials with eszopiclone, one case of overdose with up to 36 mg of eszopiclone was reported in which the subject fully recovered. Since commercial marketing began, spontaneous cases of eszopiclone overdoses up to 270 mg (90 times the maximum recommended dose of eszopiclone) have been reported, in which patients have recovered. Fatalities related to Lunesta overdoses were reported only in combination with other CNS drugs or alcohol.


    Contraindications:

  • Patients who have experienced complex sleep behaviors after taking Lunesta.
  • Known hypersensitivity to eszopiclone.


    Warnings and precautions:

  • CNS Depressant Effects: impaired alertness and motor coordination, including risk of morning impairment. Risk increases with dose and use with other CNS depressants and alcohol. Caution patients taking 3 mg dose against driving and against activities requiring complete mental alertness during the morning after use.
  • Evaluate for Comorbid Diagnoses: reevaluate if insomnia persists after 7 to 10 days of use.
  • Severe Anaphylactic/Anaphylactoid Reactions (angioedema and anaphylaxis have been reported): do not rechallenge if such reactionsoccur.
  • Abnormal Thinking and Behavioral Changes: changes including decreased inhibition, bizarre behavior, agitation and depersonalization have been reported. Immediately evaluate any new onset of behavioral changes.
  • Worsening of Depression or Suicidal Thinking may occur: prescribe the least number of tablets feasible to avoid intentional overdose.
  • Withdrawal Effects: symptoms may occur with rapid dose reduction or discontinuation.
  • Elderly Patients: use lower dose due to impaired motor, cognitive performance and increased sensitivity.
  • Patients with Hepatic Impairment, Impaired Respiratory Function, Impaired Drug Metabolism or Hemodynamic Responses: use withcaution.


    Side effects, adverse reactions:

    Most commonly observed adverse reactions (incidence >= 2%) were unpleasant taste, headache, somnolence, respiratory infection, dizziness, dry mouth, rash, anxiety, hallucinations, and viral infections.

    To report suspected adverse reactions, contact Sunovion Pharmaceuticals Inc. or your local FDA.


    Drug interactions:

  • CNS Depressants: additive CNS-depressant effects with combination use. Use with ethanol causes additive psychomotor impairment.
  • Rifampicin: combination use may decrease exposure and effects of Lunesta.
  • Ketoconazole: combination use increases exposure and effect of Lunesta. Dose reduction of Eszopiclone is needed.


    Use in specific populations:

    Pediatric use: safety and effectiveness not established. Dizziness, dysgeusia, hallucinations, suicidal ideation reported.


    Pregnancy categories:

  • Not classified - Australia
  • C - United States (Risk cannot be ruled out)


    Salts and other forms:

  • Eszopiclone Base


    Synonyms, international and chemical names:

  • (+)-Zopiclone
  • (S)-Zopiclone
  • Dextrorotatory stereoisomer of Zopiclone
  • Esopiclone
  • Eszopiclon
  • Eszopiclona
  • Eszopicloni
  • Eszopiclonum
  • Eszopiklon
  • Plus-Zopiclone


    Brands, generics, trade names:

  • Estorra - Sepracor Pharmaceuticals
  • Eszop - Silesia Laboratorios
  • Eszopiclone - Dr. Reddy's Laboratories, Lupin Pharmaceuticals, Mylan, Roxane Laboratories, Sun Pharmaceutical Industries, Teva
  • Fulnite - Sun Pharmaceutical Industries
  • JustSleep - Emcure Pharmaceuticals
  • Lunesta - Sepracor Pharmaceuticals
  • Night Calm - Medizen Pharmaceutical Industries
  • Nirvan - Saval Laboratorios
  • Novo Insomnium - Gador
  • Plessir - Medipharm
  • Sleepez - ChemiPharm
  • Valnoc - Drugtech Laboratorio
  • Zopimin - Psyco Remedies
  • Zunestar - Hab Pharmaceuticals & Research


    Here is a list of popular medications containing eszopiclone as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
    Fulnite
  • Tablets; Oral; Eszopiclone 1 mg
  • Tablets; Oral; Eszopiclone 2 mg
  • Sun Pharmaceutical Industries
  • JustSleep
  • Tablets; Oral; Eszopiclone 2 mg
  • Emcure Pharmaceuticals
  • Lunesta
  • Tablets; Oral; Eszopiclone 1 mg
  • Tablets; Oral; Eszopiclone 2 mg
  • Tablets; Oral; Eszopiclone 3 mg
  • Sepracor Pharmaceuticals
  • Eisai
  • Sunovion Pharmaceuticals
  • Lunivia
  • Tablets; Oral; Eszopiclone 2 mg
  • Tablets; Oral; Eszopiclone 3 mg
  • Sepracor Pharmaceuticals
  • GlaxoSmithKline
  • Novo Insomnium
  • Tablets, Film-Coated; Oral; Eszopiclone 2 mg
  • Tablets, Film-Coated; Oral; Eszopiclone 3 mg
  • Gador
  • Sleepez
  • Tablets, Film-Coated; Oral; Eszopiclone 1 mg
  • Tablets, Film-Coated; Oral; Eszopiclone 2 mg
  • Tablets, Film-Coated; Oral; Eszopiclone 3 mg
  • ChemiPharm
  • Valnoc
  • Tablets, Film-Coated; Oral; Eszopiclone 2 mg
  • Tablets, Film-Coated; Oral; Eszopiclone 3 mg
  • Drugtech Laboratorio
  • Farmindustria
  • Recalcine Laboratorios
  • Synthesis Laboratorios
  • Zopimin
  • Tablets; Oral; Eszopiclone 1 mg
  • Tablets; Oral; Eszopiclone 2 mg
  • Psyco Remedies
  • Zunestar
  • Tablets; Oral; Eszopiclone 2 mg
  • Tablets; Oral; Eszopiclone 3 mg
  • Hab Pharmaceuticals & Research



  • References:

  • Eszopiclone main article on Wikipedia: https://en.wikipedia.org/wiki/Eszopiclone
  • Eszopiclone compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Eszopiclone
  • Eszopiclone on DrugBank: https://go.drugbank.com/drugs/DB00402
  • Eszopiclone FAQ on MedlinePlus (revised 12/15/2019): https://medlineplus.gov/druginfo/meds/a605009.html
  • Lunesta (Eszopiclone) coated tablets drug label info on DailyMed (revised June 25, 2020): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
  • Eszopiclone Glenmark film-coated tablets drug label info on DailyMed (revised October 18, 2019): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
  • Eszopiclone containing drugs on Drugs-About.com: https://drugs-about.com/ing/eszopiclone.html
  • Eszopiclone for sale on Pharma Doctor (revised November 2021): https://pharma-doctor.com/eszopiclone.html
  • Lunesta (Eszopiclone) 1 mg, 2 mg, 3 mg tablets for oral use official prescribing information and medication guide from the U.S. FDA (revised 05/2014): https://www.accessdata.fda.gov/drugsatfda_docs/label...
  • Lunesta (Eszopiclone) tablets for oral use prescribing information and medication guide from Sunovion Pharmaceuticals Inc. (revised 08/2019): https://www.lunesta.com/PostedApprovedLabelingText.pdf

    Revised: November 2021



    Home | Research | About Us | Students | Board Members | Online Resources | Donors | Eszopiclone | Cyproheptadine | Selegiline | Research Grant | Awards | Contact Us

    Copyright © 2007 - 2021 Foundation for Life Care Planning Research (FLCPR). All rights reserved.